TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Eql Pharma AB
Closing information (x1000 SEK)
| Closing information | 2023/03 (consolidated) | 2022/03 (consolidated) | 2021/03 (consolidated) |
| Turnover |
409,753
|
179,141 | |
| Financial expenses |
2,874
|
1,004 | |
| Earnings before taxes |
35,965
|
10,440 | |
| EBITDA |
45,018
|
28,720 | |
| Total assets |
237,888
|
198,826 | |
| Current assets |
123,452
|
97,938 | |
| Current liabilities |
98,757
|
94,931 | |
| Equity capital |
123,626
|
91,295 | |
| - share capital |
1,308
|
1,308 | |
| Employees (average) |
18
|
13
|
10 |
Financial ratios
| Fiscal year | 2023/03 (consolidated) | 2022/03 (consolidated) | 2021/03 (consolidated) |
| Solvency |
52.0%
|
45.9% | |
| Turnover per employee |
31,519
|
17,914 | |
| Profit as a percentage of turnover |
8.8%
|
5.8% | |
| Return on assets (ROA) |
16.3%
|
5.8% | |
| Current ratio |
125.0%
|
103.2% | |
| Return on equity (ROE) |
29.1%
|
11.4% | |
| Change turnover |
230,612
|
107,112 | |
| Change turnover % |
-37%
|
129%
|
149% |
| Chg. No. of employees |
5
|
3
|
2 |
| Chg. No. of employees % |
38%
|
30%
|
25% |
Total value of public sale
| Fiscal year | 2023/03 (consolidated) | 2022/03 (consolidated) | 2021/03 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.